News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Akorn, Inc. (AKN) Announces Development and Supply Agreement with Hyaluron Contract Manufacturing (HCM) For Two Injectable ANDA Suspension Drug Products


7/30/2007 12:08:03 PM

BUFFALO GROVE, Ill.--(BUSINESS WIRE)--Akorn, Inc. (NASDAQ:AKRX) today announced the signing of a development and supply agreement with Hyaluron Contract Manufacturing, Inc. (HCM), an innovative leader in aseptic formulation and filling of liquid parenterals located in Burlington, Massachusetts. The Agreement provided for two ANDA injectable suspension products with a 2006 market size of approximately $220 million, according to IMS sales data.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES